How the cheese-noodle principle could help counter Alzheimer’s

Researchers at the Paul Scherrer Institute PSI have clarified how spermine – a small molecule that regulates many processes in the body’s cells – can guard against diseases such as Alzheimer’s and Parkinson’s: it renders certain proteins harmless by acting a bit like cheese on noodles, making them clump together. This discovery could help combat such diseases. The study has now been published in the journal Nature Communications.

Our life expectancy keeps rising – and as it does, age-related illnesses, including neurodegenerative diseases such as Alzheimer’s and Parkinson’s, become increasingly common. These diseases are caused by accumulations in the brain of harmful protein structures consisting of incorrectly folded amyloid proteins. Their shape is reminiscent of fibres or spaghetti. To date, there is no effective therapy to prevent or eliminate such accumulations.

Yet a naturally occurring molecule in the body called spermine offers hope. In experiments, researchers led by study leader Jinghui Luo, in the Center for Life Sciences at the Paul Scherrer Institute PSI, have discovered that this substance is capable of extending the life span of small nematode worms, improving their mobility in old age, and strengthening the powerhouses of their cells – the mitochondria. Specifically, the researchers observed how spermine helps the body’s immune system eliminate nerve-damaging accumulations of amyloid proteins. 

The new findings could serve as a basis for developing novel therapies for such diseases.

A central mediator of cellular processes

Spermine is a vital substance for the organism. It belongs to the so-called polyamines, which are relatively small organic molecules. Spermine, first discovered more than 150 years ago, is named after the seminal fluid, as it is found in particularly high concentrations there. But it also occurs in many other cells of the body – especially those that are active and capable of dividing.

Spermine promotes cell mobility and activity and controls numerous processes. Above all, it interacts with the nucleic acids of the genome, regulating the expression of genes and their conversion into proteins. This ensures that cells can properly grow and divide and ultimately die. Spermine is also central to an important cellular process called biomolecular condensation: In this process, certain macromolecules, such as proteins and nucleic acids, segregate and collect within the cell in a droplet-like form, so that important reactions can take place there.

In connection with neurodegenerative diseases such as Alzheimer’s or Parkinson’s, there has previously been evidence that spermine can protect nerve cells and alleviate age-related memory loss. Lacking until now, however, has been a more precise understanding of how spermine intervenes in nerve-damaging processes – understanding that might make it possible to derive medical benefits from it.

Assisting cellular waste removal

Jinghui Luo’s group has now investigated this in more detail. In addition to optical microscopy, the researchers also used the SAXS scattering technique at PSI’s Swiss Light Source SLS to shed light on the molecular dynamics of these processes. The investigations were conducted both in a glass capillary (in vitro) and in a living organism (in vivo). The nematode C. elegans served as a model organism.

Read more on the PSI website

Image: Jinghui Luo is a researcher at the Center for Life Sciences at the Paul Scherrer Institute PSI. He studies accumulations of so-called amyloid proteins, which lead to nerve damage in the brain. His research aims to help mitigate neurodegenerative diseases such as Alzheimer’s and Parkinson’s in the long term.

Credit: © Paul Scherrer Institute PSI/Markus Fischer

Possible early diagnosis of Parkinson’s disease: iron distribution in brain regions

The neurotransmitter dopamine is primarily known as the happiness hormone that controls our motivation in the brain’s reward system. However, the neurotransmitter also acts as lubricating oil for our fine motor skills and regulates the movements of our muscles. If dopamine-producing nerve cells die off, affected people experience movement disorders such as tremors or muscle stiffness. The diagnosis: Parkinson’s disease. Researchers suspect that the reason for the death of nerve cells is excessive iron concentrations in the brain.

A team of researchers from Germany and the UK has now developed a method that can be used to determine the iron concentration in the affected regions. With the participation of DESY researchers Gerald Falkenberg and Dennis Brückner, the team led by Evgeniya Kirilina from the Max Planck Institute for Human Cognitive and Brain Sciences in Leipzig, was able to determine possible toxic iron concentrations from MRI (magnetic resonance imaging) measurements of cells using DESY’s brilliant X-ray light source PETRA III. The work could contribute to the development of early diagnoses for Parkinson’s disease.

Parkinson’s disease is one of the most common diseases of the nervous system, affecting around 200,000 people in Germany alone. There is currently no cure for the disease. The typical Parkinson’s symptoms are caused by damaged nerve cells in the substantia nigra, an area in the brain stem. Damaged or dead nerve cells no longer produce enough dopamine or any dopamine at all – the lack of dopamine disrupts signal transmission between the nerve cells.

Iron is required for dopamine production in the nerve cells, and the corresponding nerve cells in the substantia nigra are therefore susceptible to both iron deficiency and excessive amounts of iron. Too much intracellular iron can be toxic, leading to the degeneration and death of neurons in the substantia nigra. “Oxidative stress caused by iron is considered a possible cause of the death of dopamine-producing nerve cells,” says DESY researcher Gerald Falkenberg, head of beamline P06 at DESY’s research X-ray source PETRA III. “That is why we have been looking for methods to measure the amount and distribution of iron in the brain over the course of a person’s life.” According to Falkenberg, this should also be possible for patients in hospitals in the future.

Read more on DESY website

Image: Iron deposits (red) in brain tissue: Using X-ray fluorescence measurements at DESY’s X-ray light source PETRA III, researchers were able to map the iron concentrations in nerve cells of the substantia nigra (region in the brain stem). The cell bodies (yellow) of the dopamine-producing nerve cells have a very high iron concentration.

Credit: E. Kirilina, Department of Neurophysics, MPI for Human Cognitive and Brain Sciences, Leipzig, Germany

Towards a therapy for Parkinson’s disease

Over 100,000 Canadians are living with Parkinson’s disease and 25 more are diagnosed every day, according to Parkinson Canada.

Patients experience tremors, stiffness, and difficulty with movement. Dr. Jean-Francois Trempe, an Associate Professor with McGill University, and colleagues are using the Canadian Light Source (CLS) at the University of Saskatchewan to help search for potential drug targets for the disease.

“I work on a set of proteins that are involved in quality control,” said Trempe. “These proteins are able to sort the damaged proteins from the non-damaged proteins and they send the damaged ones off to be degraded and that’s important for the long-term survival of neurons.”

His team used bright synchrotron light at the CLS to gain insights into a protein involved in formation of flagella, which are important notably for fluid circulation in the brain. By finding new information about this protein, their team is contributing to a body of knowledge that will hopefully lead to a therapy down the road.

Read more and watch the video on the CLS website